Literature DB >> 21097554

Concomitant trastuzumab with thoracic radiotherapy: a morphological and functional study.

G Yavas1, F Yildiz2, S Guler3, M F Sargon4, D Yildiz1, T Yolcu1, M Tuncer3, F H Akyol1.   

Abstract

BACKGROUND: The purpose of this study is to elucidate if there is an additive or supra-additive toxic effects of radiotherapy (RT) and trastuzumab (T) on vascular structures when used concomitantly.
METHODS: Female Wistar albino rats were treated with either 8 or 15 Gy of thoracic RT. T was applied i.p. with a dose of 6 mg/kg 2 h before RT. Four rats in each arm were killed at 6th h, 21st and 70th days after irradiation and thoracic aorta of each animal was dissected for electron microscopy. In addition, functional studies for evaluating the relaxation and contraction were carried out 21 days after RT.
RESULTS: Only 15-Gy RT dose groups showed significant difference in terms of functional deterioration as more contraction than the others (P < 0.05) without any difference between RT and RT + T. However, T produced additional deficit in relaxation when added to RT, which was considered near significant (P: 0.0502). Electron microscopy showed endothelial and subendotelial damage signs in 15-Gy dose groups. T + 15-Gy arm showed more pronounced endothelial cell damage than 15-Gy RT-only arm, 70 days after RT.
CONCLUSION: T and high-dose RT may lead to vascular damage that seems at least additive.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21097554     DOI: 10.1093/annonc/mdq590

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  5 in total

1.  Diastolic Dysfunction Occurs Early in HER2-Positive Breast Cancer Patients Treated Concurrently With Radiation Therapy and Trastuzumab.

Authors:  Lu Cao; Gang Cai; Cai Chang; Ai-Yu Miao; Xiao-Li Yu; Zhao-Zhi Yang; Jin-Li Ma; Qian Zhang; Jiong Wu; Xiao-Mao Guo; Jia-Yi Chen
Journal:  Oncologist       Date:  2015-05-01

2.  Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy.

Authors:  Guler Yavas; Esin Celik; Cagdas Yavas; Cagdas Elsurer; Rengin Elsurer Afsar
Journal:  Rep Pract Oncol Radiother       Date:  2017-05-05

3.  Trastuzumab aggravates radiation induced cardiotoxicity in mice.

Authors:  Peiqiang Yi; Huan Li; Jun Su; Jialin Cai; Cheng Xu; Jiayi Chen; Lu Cao; Min Li
Journal:  Am J Cancer Res       Date:  2022-01-15       Impact factor: 6.166

Review 4.  Preparation and Evaluation of Animal Models of Cardiotoxicity in Antineoplastic Therapy.

Authors:  Chenchen Meng; Lu Fan; Xiaoming Wang; Yunjiao Wang; Yanyang Li; Shuchao Pang; Shichao Lv; Junping Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-07-05       Impact factor: 7.310

5.  Dosimetric comparison of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for left-sided chest wall and lymphatic irradiation.

Authors:  Huseyin Kivanc; Melis Gultekin; Murat Gurkaynak; Gokhan Ozyigit; Ferah Yildiz
Journal:  J Appl Clin Med Phys       Date:  2019-11-03       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.